Gilead Sciences vs Tharimmune
Gilead Sciences vs Tharimmune, compared side by side on 12 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Gilead Sciences is on Not scored yet and Tharimmune on 53/100.
Where each one leads
Gilead Sciences
- agent readiness: 41/100 against 31/100
- domain rating: 82/100 against 26/100
- headcount: 14,616 against 13
- LinkedIn following: 818,832 against 1,718
Tharimmune
Leads on none of the measures we hold for both companies.
At a glance
| Measure | Gilead Sciences | Tharimmune |
|---|---|---|
| What it is | Biopharmaceutical company focused on developing and commercializing innovative medicines. | Biotechnology company developing novel immunotherapies for cancer. |
| Category | Biotech, MedTech, HealthTech, Drug Discovery | Biotech, MedTech, HealthTech, Drug Discovery |
| Sells toBusiness model | B2B | B2B |
| Offering | Biotech | Services |
| Founded | 1987 | 2017 |
| Headquarters | Foster City, United States | Cambridge, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Gilead Sciences | Tharimmune |
|---|---|---|
| Employees | 14,616 | 13 |
| Open roles | 100 | Not published |
| Total funding | Not published | $540M |
| LinkedIn followers | 818,832 | 1,718 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Gilead Sciences | Tharimmune |
|---|---|---|
| StartupHub scoreOur 0-100 rating | Not published | 53/100 |
| Traction | Not published | 51/100 |
| Team | Not published | 70/100 |
| Community | Not published | 15/100 |
| Search visibility | Not published | 22/100 |
| Quality | Not published | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (41/100) | F (31/100) |
| Domain ratingLink authority, 0-100 | 82/100 | 26/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Gilead Sciences | Tharimmune |
|---|---|---|
| CDN | Cloudflare | Cloudflare |
| CMS | Not detected | Webflow |
| Frameworks | Tailwind CSS, Bootstrap | Not detected |
| Analytics | Google Tag Manager | Not detected |
Gilead Sciences vs Tharimmune: common questions
Which is better, Gilead Sciences or Tharimmune?
On our 0-100 score Tharimmune rates higher (53/100 against Not scored yet). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 12 data points above: read the rows that match what you are buying for.
How do Gilead Sciences and Tharimmune compare on the numbers?
Gilead Sciences leads on agent readiness (41/100 against 31/100), domain rating (82/100 against 26/100), headcount (14,616 against 13), LinkedIn following (818,832 against 1,718).
Read the full Gilead Sciences review and pricing or the Tharimmune review and pricing. You can also browse other Gilead Sciences alternatives we track.